Fonseca VC, Van V, Ip BC. Primary Human Cell-Derived Extracellular Matrix from Decellularized Fibroblast Microtissues with Tissue-Dependent Composition and Microstructure. Cellular and molecular bioengineering. 2024;17(3):189-201. doi:10.1007/s12195-024-00809-yDOIGoogle ScholarPubMed
Hess A, Gentile SD, Ben Saad A, et al. Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease. The EMBO journal. 2023;42(24):e113898. doi:10.15252/embj.2023113898DOIGoogle ScholarPubMed
Chen Z, Ghavimi SAA, Wu M, et al. PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells. JCI insight. 2023;8(24). doi:10.1172/jci.insight.165324DOIGoogle ScholarPubMed
Ahlberg G, Refsgaard L, Lundegaard PR, et al. Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation. Nat Commun. 2018;9(1):4316. doi:10.1038/s41467-018-06618-yDOIGoogle ScholarPubMed
Jasso GJ, Jaiswal A, Varma M, et al. Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing. PLoS Biol. 2022;20(1):e3001532. doi:10.1371/journal.pbio.3001532DOIGoogle ScholarPubMed
Ikeda Y, Sun Z, Ru X, Vandenberghe LH, Humphreys BD. Efficient Gene Transfer to Kidney Mesenchymal Cells Using a Synthetic Adeno-Associated Viral Vector. J Am Soc Nephrol. 2018;29(9):2287-2297. doi:10.1681/ASN.2018040426DOIGoogle ScholarPubMed
Cheng L, Desai J, Miranda CJ, et al. Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling. Neuron. 2014;82(2):334-49. doi:10.1016/j.neuron.2014.02.038DOIGoogle ScholarPubMed
Whitman MC, Andrews C, Chan WM, et al. Two unique TUBB3 mutations cause both CFEOM3 and malformations of cortical development. Am J Med Genet A. 2016;170A(2):297-305. doi:10.1002/ajmg.a.37362DOIGoogle ScholarPubMed